文献速递免疫规划

伪狂犬病毒R2非嗜神经疫苗:猪概念验证研究

The pseudorabies virus R2 non-neuroinvasive vaccine: A proof-of-concept study in pigs.
PubMed 文献 · Vaccine · 2020-05-22

本研究在猪模型中评估源于α-疱疹病毒伪狂犬病毒(PRV)的R2疫苗特性与效力。结果显示R2疫苗在检测限内不侵入猪外周神经系统,且单次鼻内接种后对强毒PRV野毒株(NIA-3)攻击提供保护。表明R2疫苗设计具非嗜神经性,在自然宿主中有效。

要点

  • R2疫苗在猪检测限内不侵入外周神经系统。
  • 单次鼻内接种R2可保护猪抵抗强毒PRV NIA-3攻击。
  • R2疫苗设计在自然宿主中具非嗜神经性与有效性。

核心结论

  • PRV R2疫苗在猪中不侵入外周神经系统且单次鼻内接种可抵抗强毒PRV攻击。

研究设计与样本

  • 在猪中评估源于α-疱疹病毒PRV的R2疫苗特性与效力的概念验证研究。

主要发现

  • R2疫苗在检测限内不侵入猪外周神经系统。
  • 单次鼻内接种后R2对强毒PRV野毒株NIA-3攻击提供保护。

临床怎么用

  • 支持R2疫苗设计作为非嗜神经且有效的疫苗策略在自然宿主中应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neurotropic alpha-herpesviruses that infect mammals establish life-long latent infections in the peripheral nervous system after initial infection of exposed mucosal tissues. The neuroinvasive properties can lead to severe complications both with clinical and veterinary alpha-herpesviruses, and vaccines are often unavailable or provide limited protection. Here we assess the properties and efficacy of an R2 vaccine derived from the alpha-herpesvirus, pseudorabies virus (PRV), in pigs. We demonstrate that the PRV R2 vaccine does not invade the porcine peripheral nervous system within the limits of detection. Furthermore, after a single intranasal vaccination, R2 conferred protection to pigs subsequently challenged with a virulent PRV field strain (NIA-3). These findings support that the R2 vaccine design is non-neuroinvasive and is an effective vaccine in the context of a natural host.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Pickard GE, Brodersen B, Sollars PJ, et al. The pseudorabies virus R2 non-neuroinvasive vaccine: A proof-of-concept study in pigs. Vaccine. 2020. PMID: 32448623. doi:10.1016/j.vaccine.2020.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。